Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chemokines in renal diseases.

Stephan Segerer1, Peter J Nelson

  • 1Klinikum der Universität, Medizinische Poliklinik-Innenstadt, University of Munich, Pettenkoferstr. 8a, 80336 Munich, Germany. Stephan.segerer@lrz.uni-muenchen.de

Thescientificworldjournal
|October 4, 2005
PubMed
Summary

Chemokines, signaling proteins, guide immune cells and impact kidney diseases. Blocking chemokine receptors shows therapeutic potential for renal conditions, with receptor expression linked to disease severity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ten tips to preserve and reuse water in nephrology.

Clinical kidney journal·2026
Same author

Long-term citrate treatment in high-risk kidney stone formers is not associated with metabolic adverse effects.

Clinical kidney journal·2026
Same author

Hypoxia inducible factor network reflects kidney disease progression in diabetes and sodium-glucose co-transporters inhibition.

Signal transduction and targeted therapy·2026
Same author

Deep biochemical phenotyping reveals prognostic value of rare genetic variants in adult kidney stone disease.

The Journal of clinical investigation·2026
Same author

Wnt-associated DKK3 in keratinocytes mediates radiation-induced hyperplasia, dermatitis and skin fibrosis.

Signal transduction and targeted therapy·2026
Same author

DARC and Anti-Duffy Antibodies in the Line of Fire: The Challenges in Pinpointing the Etiology of Microcirculation Inflammation to a Distinct Entity.

Transplant international : official journal of the European Society for Organ Transplantation·2026

Area of Science:

  • Immunology
  • Nephrology
  • Molecular Biology

Background:

  • Chemokines are cytokines that direct immune cell migration and function.
  • They play roles in inflammation, proliferation, angiogenesis, and various diseases.
  • Their involvement in renal diseases has been a focus of recent research.

Purpose of the Study:

  • To review recent developments in chemokines and chemokine receptors in renal diseases since mid-2003.
  • To explore the therapeutic potential of chemokine receptor blockade in kidney diseases.
  • To examine the correlation between chemokine receptor expression and renal disease progression in humans.

Main Methods:

  • Review of recent scientific literature (post-2003) on chemokines in renal diseases.
  • Analysis of animal models demonstrating chemokine involvement in kidney injury.
  • Examination of human studies on chemokine receptor expression in inflammatory cells within kidney tissues.

Main Results:

  • Chemokines are produced at injury sites, recruiting inflammatory cells in animal models.
  • Therapeutic blockade of chemokine receptors (CCR1, CCR2, CCR4, CCR5) has been studied in renal disease models.
  • Expression of CXCR1, CXCR3, CCR2, and CCR5 on inflammatory cells is observed in human kidney diseases.
  • CCR5 and CXCR3 expression correlates with renal function and proteinuria in glomerular diseases.
  • Chemokine and receptor polymorphisms affect renal disease course and allograft survival.

Conclusions:

  • Chemokines are critical players in the pathogenesis of renal diseases.
  • Chemokine receptor blockade is a promising therapeutic strategy for kidney diseases.
  • Further clinical applications of chemokine receptor blockade in nephrology are anticipated.

Related Experiment Videos